We integrated the experimental findings on AICD and Aβ and presented prediction of the complex interaction effects of AD peptides and the influence of partial GluN2B-NMDAR blockade to normalize the properties of synaptic plasticity. This evidence concerns the gene GRIN2B and Alzheimer disease.